The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agents
- 1 February 2010
- journal article
- Published by Elsevier in Biomaterials
- Vol. 31 (5), 923-933
- https://doi.org/10.1016/j.biomaterials.2009.09.101
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 R01CA089225, R01CA116590)
This publication has 38 references indexed in Scilit:
- Transepithelial transport of PEGylated anionic poly(amidoamine) dendrimers: Implications for oral drug deliveryJournal of Controlled Release, 2009
- Caveolae-mediated Internalization of Occludin and Claudin-5 during CCL2-induced Tight Junction Remodeling in Brain Endothelial CellsJournal of Biological Chemistry, 2009
- Epithelial cell–cell junctions and plasma membrane domainsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2009
- Different Internalization Pathways of Polymeric Micelles and Unimers and Their Effects on Vesicular TransportBioconjugate Chemistry, 2008
- The effect of particle design on cellular internalization pathwaysProceedings of the National Academy of Sciences, 2008
- Caveolae and transcytosis in endothelial cells: role in atherosclerosisCell and tissue research, 2008
- Polymer conjugates as anticancer nanomedicinesNature Reviews Cancer, 2006
- Recent advances with liposomes as pharmaceutical carriersNature Reviews Drug Discovery, 2005
- Bcl-2 expression decreases cadherin-mediated cell-cell adhesionJournal of Cell Science, 2003
- Engineering liposomes for drug delivery: progress and problemsTrends in Biotechnology, 1995